These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23176657)

  • 1. Pre-erythrocytic malaria vaccines: identifying the targets.
    Duffy PE; Sahu T; Akue A; Milman N; Anderson C
    Expert Rev Vaccines; 2012 Oct; 11(10):1261-80. PubMed ID: 23176657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
    Bettencourt P
    Front Immunol; 2020; 11():190. PubMed ID: 32153565
    [No Abstract]   [Full Text] [Related]  

  • 3. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
    Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-stage immunity for malaria vaccine development.
    Nahrendorf W; Scholzen A; Sauerwein RW; Langhorne J
    Vaccine; 2015 Dec; 33(52):7513-7. PubMed ID: 26469724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing malaria vaccines to circumvent antigen variability.
    Ouattara A; Barry AE; Dutta S; Remarque EJ; Beeson JG; Plowe CV
    Vaccine; 2015 Dec; 33(52):7506-12. PubMed ID: 26475447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The March Toward Malaria Vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S319-33. PubMed ID: 26590432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pre-erythrocytic malaria antigens that target hepatocytes for killing in vivo and contribute to protection elicited by whole-parasite vaccination.
    Chen L; Keitany GJ; Peng X; Gibson C; Mohar I; Vignali M; Crispe IN; Huang F; Wang R
    PLoS One; 2014; 9(7):e102225. PubMed ID: 25025375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and evaluation of a multistage combination vaccine against malaria.
    Zhang Q; Xue X; Qu L; Pan W
    Vaccine; 2007 Mar; 25(11):2112-9. PubMed ID: 17241708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.
    Steel RW; Kappe SH; Sack BK
    Future Microbiol; 2016 Dec; 11(12):1563-1579. PubMed ID: 27855488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    Speake C; Pichugin A; Sahu T; Malkov V; Morrison R; Pei Y; Juompan L; Milman N; Zarling S; Anderson C; Wong-Madden S; Wendler J; Ishizuka A; MacMillen ZW; Garcia V; Kappe SH; Krzych U; Duffy PE
    PLoS One; 2016; 11(7):e0159449. PubMed ID: 27434123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporozoite antigens: biology and immunology of the circumsporozoite protein and thrombospondin-related anonymous protein.
    Sinnis P; Nardin E
    Chem Immunol; 2002; 80():70-96. PubMed ID: 12058652
    [No Abstract]   [Full Text] [Related]  

  • 14. The case for a subunit vaccine against malaria.
    Anders RF
    Trends Parasitol; 2011 Aug; 27(8):330-4. PubMed ID: 21592861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A whole parasite vaccine to control the blood stages of Plasmodium: the case for lateral thinking.
    Good MF
    Trends Parasitol; 2011 Aug; 27(8):335-40. PubMed ID: 21514227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing protective immune responses against the sporozoite and liver stages of Plasmodium.
    Hoffman SL; Franke ED
    Immunol Lett; 1994 Jul; 41(2-3):89-94. PubMed ID: 8002054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
    Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
    BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.
    Takala SL; Plowe CV
    Parasite Immunol; 2009 Sep; 31(9):560-73. PubMed ID: 19691559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.
    Taylor-Robinson AW
    Expert Rev Vaccines; 2002 Oct; 1(3):317-40. PubMed ID: 12901572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designer Parasites: Genetically Engineered
    Goswami D; Minkah NK; Kappe SHI
    J Immunol; 2019 Jan; 202(1):20-28. PubMed ID: 30587570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.